DCGI's expert panel recommends Phase 3 clinical trial nod for Bharat Biotech's Covid-19 vaccine

The expert panel at Central Drugs Standard Control Organisation (CDSCO) has recommended the top drugs regulator to grant permission to Bharat Biotech to conduct phase III clinical trial using indigenous covid19 vaccine--Covaxin, with subject to the condition. "In continuation of the Subject Expert Committee (SEC) meeting dated 5...